Related references
Note: Only part of the references are listed.Ordered Mesoporous Polymer-Silica Hybrid Nanoparticles as Vehicles for the Intracellular Controlled Release of Macromolecules
Tae-Wan Kim et al.
ACS NANO (2011)
Multifunctional Mesoporous Silica Nanoparticles for Combined Therapeutic, Diagnostic and Targeted Action in Cancer Treatment
Jessica M. Rosenholm et al.
CURRENT DRUG TARGETS (2011)
Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility
Qianjun He et al.
JOURNAL OF MATERIALS CHEMISTRY (2011)
Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands
Huixia Wu et al.
JOURNAL OF MATERIALS CHEMISTRY (2011)
PEG-templated mesoporous silica nanoparticles exclusively target cancer cells
Catia Morelli et al.
NANOSCALE (2011)
Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers
Amirali Popat et al.
NANOSCALE (2011)
Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells
Daniel P. Ferris et al.
SMALL (2011)
Poly-L-lysine-coated albumin nanoparticles: Stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics
Harsh Deep Singh et al.
ACTA BIOMATERIALIA (2010)
Silicalites and Mesoporous Silica Nanoparticles for photodynamic therapy
Ouahiba Hocine et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics-the trio of imaging, targeting and therapy
Shih-Hsun Cheng et al.
JOURNAL OF MATERIALS CHEMISTRY (2010)
Targeting of Porous Hybrid Silica Nanoparticles to Cancer Cells
Jessica M. Rosenholm et al.
ACS NANO (2009)
Biotin-Avidin as a Protease-Responsive Cap System for Controlled Guest Release from Colloidal Mesoporous Silica
Axel Schlossbauer et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells
Chih-Pin Tsai et al.
JOURNAL OF MATERIALS CHEMISTRY (2009)
Mechanised nanoparticles for drug delivery
Karla K. Coti et al.
NANOSCALE (2009)
Advances in alpha(v)beta(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides
Petar M. Mitrasinovic
CURRENT RADIOPHARMACEUTICALS (2009)
Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers
Igor I. Slowing et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane, penetration
Brian G. Trewyn et al.
CHEMICAL ENGINEERING JOURNAL (2008)
Integrin trafficking and its role in cancer metastasis
Alan G. Ramsay et al.
CANCER AND METASTASIS REVIEWS (2007)
Interest of RGD-containing linear or cyclic peptide targeted tetraphenylchlorin as novel photosensitizers for selective photodynamic activity
Celine Frochot et al.
BIOORGANIC CHEMISTRY (2007)
The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by αVβ3 integrin in human breast cancer cells
Kulrut Borrirukwanit et al.
MATRIX BIOLOGY (2007)
Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems
Brian G. Trewyn et al.
CHEMICAL COMMUNICATIONS (2007)
Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticleson the endocytosis by human cancer cells
Igor Slowing et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Cell adhesion molecules for targeted drug delivery
Alison L. Dunehoo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
U Hersel et al.
BIOMATERIALS (2003)
Share Paper
